Resverlogix Corp. has announced key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting. The presentation titled “Compound RVX-208 Modulates HDL-C Levels and Function in Non-human Primates and in Early Human Trials” was presented by Dr. Jacques Genest.
Navigation
Daily News
- Public Engagement Grants 2010 – Applications Open – British Psychological Society
- New Report Published On Social Care, England
- Are Cities Designed For Women? Penn-ICOWHI Conference Examines Urban Women’s Health
- Stimuvax Will Become Decision Resources’ Proprietary Clinical Gold Standard For The Treatment Of Locally Advanced Non-Small-Cell Lung Cancer
- Researchers Develop Tool To Help Study Prostate Cancer
Translator
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||
| By N2H | |||||||||